as on February 2, 2026 at 11:40 pm IST
Day's Low
Day's High
0.39%
Downside
5.33%
Upside
52 Week's Low
52 Week's High
95.75%
Downside
-95.72%
Upside
Check Idexx Laboratories, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$55.8B
EPS (TTM)
12.93
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.21%
PE Ratio (TTM)
55.25
Industry PE ratio
22.595
PEG Ratio
4.1213
EBITDA
1.4B
Revenue (TTM)
4.2B
Profit Margin
24.65%
Return On Equity TTM
64.63%
Track how Idexx Laboratories, Inc. P/E has moved over time to understand its valuation trends.
Idexx Laboratories, Inc. in the last 5 years
Lowest (39.82x)
June 30, 2025
Industry (22.59x)
February 2, 2026
Today (55.25x)
February 2, 2026
Highest (76.97x)
September 30, 2021
Today’s Price to Earnings Ratio: 55.25x
Compare market cap, revenue, PE, and other key metrics of Idexx Laboratories, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $55.8B | 32.33% | 55.25 | 24.65% | |
| BUY | $235.4B | 11.59% | 36.24 | 15.02% | |
| BUY | $41.0B | 24.8% | 33.11 | 8.07% | |
| BUY | $38.5B | 8.65% | 29.75 | 18.75% | |
| BUY | $169.5B | -10.69% | 48.81 | 14.44% |
The Idexx Laboratories, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Idexx Laboratories, Inc. investment value today
Current value as on today
₹1,53,239
Returns
₹53,239
(+53.24%)
Returns from Idexx Laboratories, Inc. Stock
₹48,046 (+48.05%)
Dollar Returns*
₹5,193 (+5.19%)
Based on 19 analysts
68.42%
Buy
31.58%
Hold
0.00%
Sell
Based on 19 analysts, 68.42% of analysts recommend a 'BUY' rating for Idexx Laboratories, Inc.. Average target price of $766
Get share price movements and forecasts by analysts on Idexx Laboratories, Inc..
What analysts predicted
18.43%UPSIDE
Target Price
$766
Current Price
$624.83
Analyzed by
19 Analysts
Target
$766.00
Idexx Laboratories, Inc. target price $766, a slight upside of 18.43% compared to current price of $624.83. According to 19 analysts rating.
Search interest for Idexx Laboratories, Inc. Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:26% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 02 February
Mon, 08:12 PM
-IDEXX Laboratories reports Q4 earnings, EPS of $3.08, beating estimates, but shares drop 1.5% in pre-market trading.
Mon, 10:23 PM
-IDEXX shares slide 6% as management warns of pressure on clinical visits and declining wellness visits.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 year, IDXX stock has moved up by 58.9%
Best in 3 Years
![]()
In the last 3 years, IDXX has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
![]()
In the last 1 year, IDXX has outperformed top 5 stocks with highest market-cap in its industry
Revenue Fall
![]()
Idexx Laboratories, Inc. has experienced a decline in revenue over the last two quarters, with revenue remaining at $1.10 billion. This period saw an average decrease of 0.4% per quarter.
Profit Down
![]()
Idexx Laboratories, Inc. has experienced a decline in net profit over the last two quarters, dropping from $293.98 million to $274.61 million. This represents an average decrease of 6.6% per quarter.
| Organisation | Idexx Laboratories, Inc. |
| Headquarters | One IDEXX Drive, Westbrook, ME, United States, 04092 |
| Industry | Health Technology |
| CEO | Mr. Jonathan J. Mazelsky |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Bob Asmann | Senior Vice President of Global Operations |
Ms. Julie Godon | Senior VP & Global Marketing Officer |
Mr. Michael P. Johnson | Executive VP & Chief Human Resources Officer |
Dr. Martin Smith Ph.D. | Executive Vice President of Global Operations and R&D |
Mr. Michael J. Lane | Executive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology |
Dr. Nimrata Khatra Hunt P.E., Ph.D. | Executive Vice President of Global Strategy & Commercial |
Mr. Andrew Emerson | Executive VP, CFO & Treasurer |
Mr. Amit Gupta | Senior VP, Chief Digital & Information Officer |
Ms. Sharon E. Underberg J.D. | Executive VP, General Counsel, & Corporate Secretary |
Mr. Jonathan J. Mazelsky | President, CEO & Director |
Idexx Laboratories, Inc. share price today is $624.83 as on . Idexx Laboratories, Inc. share today touched a day high of $658.15 and a low of $622.37.
Idexx Laboratories, Inc. share touched a 52 week high of $26.75 on and a 52 week low of $26.53 on . Idexx Laboratories, Inc. stock price today i.e. is trending at $624.83,which is -2235.81% down from its 52 week high and 2255.18% up from its 52 week low.
Idexx Laboratories, Inc. market capitalisation is $0.06T as on .
Indian investors can start investing in Idexx Laboratories, Inc. (IDXX) shares with as little as ₹91.486 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹914.86 in Idexx Laboratories, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Idexx Laboratories, Inc. share’s latest price of $624.83 as on February 2, 2026 at 11:40 pm IST, you will get 0.0160 shares of Idexx Laboratories, Inc.. Learn more about
fractional shares .
Idexx Laboratories, Inc. stock has given 32.33% share price returns and 25.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?